欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2184/015
药品名称RISPERDAL CONSTA 50 mg
活性成分
    • Risperidone 50.0 mg
剂型Powder and solvent for suspension for injection
上市许可持有人Janssen-Cilag GmbH Johnson & Johnson Platz 1 41470 Neuss Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Risperdal Consta 50 mg Pulver und Lösungsmittel...
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      RISPOLEPT CONSTA
    • Latvia (LV)
      Rispolept Consta 50 mg pulveris un šķīdinātājs ilgstošas darbības injekciju suspensijas pagatavošana
    • Lithuania (LT)
      RISPOLEPT CONSTA 50 mg milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai
    • Estonia (EE)
    • Hungary (HU)
      RISPERDAL CONSTA 50 mg por és oldószer retard szuszpenziós injekcióhoz intramuszkuláris célra
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
      Rispolept Consta 50 mg pulbere si solvent pentru suspensie injectabila cu eliberare prelungita
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
许可日期2009/04/01
最近更新日期2025/01/02
药物ATC编码
    • N05AX08 risperidone
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase